Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
Clinical trial NCT04120753 · COMPLETED
Trial details
- NCT number
- NCT04120753
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2021-07-06
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.